Allworth Financial LP Has $129,000 Position in STERIS plc (NYSE:STE)

Allworth Financial LP cut its position in STERIS plc (NYSE:STE) by 9.4% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 590 shares of the medical equipment provider’s stock after selling 61 shares during the period. Allworth Financial LP’s holdings in STERIS were worth $129,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently made changes to their positions in STE. Creative Planning increased its holdings in shares of STERIS by 1.4% in the third quarter. Creative Planning now owns 9,019 shares of the medical equipment provider’s stock worth $2,187,000 after acquiring an additional 126 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. grew its position in shares of STERIS by 25.7% in the 3rd quarter. Mirae Asset Global Investments Co. Ltd. now owns 8,387 shares of the medical equipment provider’s stock valued at $2,005,000 after purchasing an additional 1,713 shares during the period. Wealth Enhancement Advisory Services LLC increased its stake in STERIS by 32.8% during the 3rd quarter. Wealth Enhancement Advisory Services LLC now owns 7,705 shares of the medical equipment provider’s stock worth $1,869,000 after purchasing an additional 1,904 shares in the last quarter. Boston Trust Walden Corp increased its stake in STERIS by 0.3% during the 3rd quarter. Boston Trust Walden Corp now owns 44,912 shares of the medical equipment provider’s stock worth $10,893,000 after purchasing an additional 118 shares in the last quarter. Finally, State of Alaska Department of Revenue raised its holdings in STERIS by 6.9% during the 3rd quarter. State of Alaska Department of Revenue now owns 11,455 shares of the medical equipment provider’s stock worth $2,778,000 after buying an additional 735 shares during the period. Institutional investors and hedge funds own 94.69% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts have issued reports on the company. JMP Securities reiterated a “market outperform” rating and set a $265.00 target price on shares of STERIS in a report on Thursday, February 6th. Piper Sandler increased their price objective on STERIS from $260.00 to $265.00 and gave the stock an “overweight” rating in a report on Monday, February 3rd. StockNews.com cut STERIS from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, October 29th. Stephens reaffirmed an “overweight” rating and set a $240.00 price target on shares of STERIS in a research note on Thursday, February 6th. Finally, Needham & Company LLC reissued a “hold” rating on shares of STERIS in a research report on Friday, November 8th. One equities research analyst has rated the stock with a hold rating and five have given a buy rating to the company. According to data from MarketBeat, STERIS has an average rating of “Moderate Buy” and a consensus price target of $258.75.

STERIS Stock Performance

Shares of STE stock opened at $220.43 on Monday. The business’s 50-day moving average price is $213.59 and its 200-day moving average price is $223.33. STERIS plc has a 12 month low of $197.82 and a 12 month high of $248.24. The company has a current ratio of 2.13, a quick ratio of 1.40 and a debt-to-equity ratio of 0.32. The firm has a market capitalization of $21.66 billion, a price-to-earnings ratio of 46.80 and a beta of 0.84.

STERIS (NYSE:STE) last released its quarterly earnings results on Wednesday, February 5th. The medical equipment provider reported $2.32 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.33 by ($0.01). STERIS had a return on equity of 13.91% and a net margin of 8.66%. Equities research analysts forecast that STERIS plc will post 9.08 EPS for the current year.

STERIS Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, March 21st. Investors of record on Thursday, February 20th will be given a dividend of $0.57 per share. The ex-dividend date is Thursday, February 20th. This represents a $2.28 annualized dividend and a dividend yield of 1.03%. STERIS’s payout ratio is 48.41%.

STERIS Company Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.